Literature DB >> 17515903

Interaction with the BRCA2 C terminus protects RAD51-DNA filaments from disassembly by BRC repeats.

Owen Richard Davies1, Luca Pellegrini.   

Abstract

BRCA2 has an essential function in DNA repair by homologous recombination, interacting with RAD51 via short motifs in the middle and at the C terminus of BRCA2. Here, we report that a conserved 36-residue sequence of human BRCA2 encoded by exon 27 (BRCA2Exon27) interacts with RAD51 through the specific recognition of oligomerized RAD51 ATPase domains. BRCA2Exon27 binding stabilizes the RAD51 nucleoprotein filament against disassembly by BRC repeat 4. The protection is specific for RAD51 filaments formed on single-stranded DNA and is lost when BRCA2Exon27 is phosphorylated on Ser3291. We propose that productive recombination results from the functional balance between the different RAD51-binding modes [corrected] of the BRC repeat and exon 27 regions of BRCA2. Our results further suggest a mechanism in which CDK phosphorylation of BRCA2Exon27 at the G2-M transition alters the balance in favor of RAD51 filament disassembly, thus terminating recombination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515903      PMCID: PMC2096194          DOI: 10.1038/nsmb1251

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  35 in total

1.  BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.

Authors:  S S Yuan; S Y Lee; G Chen; M Song; G E Tomlinson; E Y Lee
Journal:  Cancer Res       Date:  1999-08-01       Impact factor: 12.701

2.  Involvement of Brca2 in DNA repair.

Authors:  K J Patel; V P Yu; H Lee; A Corcoran; F C Thistlethwaite; M J Evans; W H Colledge; L S Friedman; B A Ponder; A R Venkitaraman
Journal:  Mol Cell       Date:  1998-02       Impact factor: 17.970

3.  The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment.

Authors:  P L Chen; C F Chen; Y Chen; J Xiao; Z D Sharp; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

4.  Purification of human Rad51 protein by selective spermidine precipitation.

Authors:  P Baumann; F E Benson; N Hajibagheri; S C West
Journal:  Mutat Res       Date:  1997-08       Impact factor: 2.433

5.  RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein.

Authors:  R Mizuta; J M LaSalle; H L Cheng; A Shinohara; H Ogawa; N Copeland; N A Jenkins; M Lalande; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

6.  RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2.

Authors:  A K Wong; R Pero; P A Ormonde; S V Tavtigian; P L Bartel
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

7.  Crystal structure of an ATPase-active form of Rad51 homolog from Methanococcus voltae. Insights into potassium dependence.

Authors:  Yan Wu; Xinguo Qian; Yujiong He; Ignace A Moya; Yu Luo
Journal:  J Biol Chem       Date:  2004-11-10       Impact factor: 5.157

8.  The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA-ssDNA junction.

Authors:  Haijuan Yang; Qiubai Li; Jie Fan; William K Holloman; Nikola P Pavletich
Journal:  Nature       Date:  2005-02-10       Impact factor: 49.962

Review 9.  The genetics of breast cancer susceptibility.

Authors:  N Rahman; M R Stratton
Journal:  Annu Rev Genet       Date:  1998       Impact factor: 16.830

10.  CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair.

Authors:  Fumiko Esashi; Nicole Christ; Julian Gannon; Yilun Liu; Tim Hunt; Maria Jasin; Stephen C West
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

View more
  98 in total

1.  Coupling of Homologous Recombination and the Checkpoint by ATR.

Authors:  Rémi Buisson; Joshi Niraj; Amélie Rodrigue; Chu Kwen Ho; Johannes Kreuzer; Tzeh Keong Foo; Emilie J-L Hardy; Graham Dellaire; Wilhelm Haas; Bing Xia; Jean-Yves Masson; Lee Zou
Journal:  Mol Cell       Date:  2017-01-12       Impact factor: 17.970

Review 2.  Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.

Authors:  Rohit Prakash; Yu Zhang; Weiran Feng; Maria Jasin
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-01       Impact factor: 10.005

Review 3.  Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis.

Authors:  Mary Ellen Moynahan; Maria Jasin
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03       Impact factor: 94.444

Review 4.  Quality control of DNA break metabolism: in the 'end', it's a good thing.

Authors:  Roland Kanaar; Claire Wyman; Rodney Rothstein
Journal:  EMBO J       Date:  2008-02-20       Impact factor: 11.598

Review 5.  The consequences of Rad51 overexpression for normal and tumor cells.

Authors:  Hannah L Klein
Journal:  DNA Repair (Amst)       Date:  2008-02-01

6.  D-loop formation by Brh2 protein of Ustilago maydis.

Authors:  Nayef Mazloum; Qingwen Zhou; William K Holloman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-03       Impact factor: 11.205

Review 7.  Homologous recombination in DNA repair and DNA damage tolerance.

Authors:  Xuan Li; Wolf-Dietrich Heyer
Journal:  Cell Res       Date:  2008-01       Impact factor: 25.617

8.  DNA-binding Domain within the Brh2 N Terminus Is the Primary Interaction Site for Association with DNA.

Authors:  Qingwen Zhou; Milorad Kojic; William K Holloman
Journal:  J Biol Chem       Date:  2009-02-01       Impact factor: 5.157

Review 9.  Functional assays for analysis of variants of uncertain significance in BRCA2.

Authors:  Lucia Guidugli; Aura Carreira; Sandrine M Caputo; Asa Ehlen; Alvaro Galli; Alvaro N A Monteiro; Susan L Neuhausen; Thomas V O Hansen; Fergus J Couch; Maaike P G Vreeswijk
Journal:  Hum Mutat       Date:  2013-12-03       Impact factor: 4.878

10.  Cyclin D1 promotes BRCA2-Rad51 interaction by restricting cyclin A/B-dependent BRCA2 phosphorylation.

Authors:  C Chalermrujinanant; W Michowski; G Sittithumcharee; F Esashi; S Jirawatnotai
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.